SPDR Rus Low Vol Focus

Voya Investment Management LLC Reduces Holdings in Cencora, Inc.

Rockingstone Advisors LLC Acquired Stocks of Omnicom Group Inc.

Wall Street Zen downgrades Regeneron Pharmaceuticals' rating from 'buy' to 'hold'

RBC Capital analyst reiterates Humana buy rating with a target price of $322

Cencora Inc. Executives Sell Common Stock

T. Rowe Price Launches Two New Active ETFs

Kwmg LLC Reduces Holdings in Cardinal Health

Omnicom Completes Acquisition of Interpublic

US Department of Defense Awards Humana a $7.3 Billion Contract

Leidos Holdings Inc. Extends Contract with Australian Maritime Safety Authority and Announces Upgrades

Humana Inc official exercised and returned stocks to disclose ownership change

Ventura Joseph C Discloses and Completes Ownership Change in Humana Inc.

AM Best Confirms Credit Ratings for Humana Inc. and its Health Insurance Subsidiary

Humana Inc. Stock Falls Amid Analyst Actions

Humana Reaffirms FY2025 EPS Guidance

Central Pacific Bank Trust Department Significantly Increases Holding in Cencora, Inc.

Cognizant and other multinational HR companies affected by new H-1B visa fees

Fitch Downgrades Humana's Ratings

T. Rowe Price and Goldman Sachs Launch First Co-Branded Model Portfolio

Fitch Confirms Cencora's Stable Outlook, Acquires OneOncology

Luminar Tech

Novabay Pharmac

Mint Incorporation

Autozi Internet Tech Global

GD Culture

Impact BioMedical

Tradr 2X Long FLY Daily ETF

Leverage Shares 2X Long CRWV Daily ETF

T-REX 2X Long CRWV Daily Target ETF

Voya Investment Management LLC reduced its stake in Cencora, Inc. by 17.7% in the 3rd quarter, now holding 373,494 shares worth $116.73 million. Other institutional investors also adjusted their positions. Analysts have mixed ratings on Cencora, with a consensus of 'Moderate Buy' and an average target price of $373.25. Cencora reported strong earnings and revenue growth, and increased its dividend. The stock has a market cap of $66.16 billion and a P/E ratio of 42.90.

Market Beat

Cencora

Voya Investment Management LLC Trims Position in Cencora, Inc. $COR

Rockingstone Advisors LLC acquired 38,965 shares of Omnicom Group Inc., valued at $3,177,000, making it their 23rd largest holding. Analysts have mixed ratings on Omnicom, with a consensus "Hold" rating and an average target price of $92.57. Omnicom's stock opened at $80.26, with a market cap of $15.49 billion. The company reported strong quarterly earnings and increased its dividend to $0.80 per share.

Omnicom

Rockingstone Advisors LLC Takes Position in Omnicom Group Inc. $OMC

REGN

Wall Street Zen downgraded Regeneron Pharmaceuticals from a "buy" to a "hold" rating. Other analysts have varied opinions, with some upgrading to "strong-buy" and others adjusting price targets. The stock has a consensus "Moderate Buy" rating with a target price of $779.45. Recent insider trading and institutional investments are also noted.

Regeneron Pharma

Regeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by Wall Street Zen

RBC Capital's Ben Hendrix maintained a Buy rating on Humana with a $322 price target. Hendrix, who covers the Healthcare sector, has a 4.6% average return and a 51.76% success rate. Jefferies also rated Humana as Buy, while Morgan Stanley maintained a Hold rating.

Tip Ranks

Humana

RBC Capital Sticks to Its Buy Rating for Humana (HUM)

CTSH

Cognizant Technology Solutions Corp's CEO, Singisetti Ravi Kumar, filed a Form 144 with the SEC to sell 8,505 shares on December 19, 2025, through JP Morgan Securities LLC, under a prearranged trading plan (10b5-1). This filing allows the sale within 90 days.

Reuters

Cognizant Tech Solutions

CEO Singisetti Files To Sell 8,505 Of Cognizant Technology Solutions Corp [CTSH]

Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora Inc., reported the sale of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This news brief was created by Public Technologies using AI and is for informational purposes only.

Cencora SVP & Chief Accounting Officer Lazarus Krikorian Reports Sale of Common Shares

Health insurance stocks, including Humana, UnitedHealthcare, Cigna, CVS Health, and Elevance Health, declined after President Trump announced plans to meet with insurers to discuss lowering prices. Trump suggested that insurers, who have profited significantly, might reduce prices by 50-70% following discussions. This announcement affected the stock performance of these companies.

Sherwoodnews

Cigna

Elevance Health

CVS Health

Health insurance stocks lose steam as Trump says he’ll lobby insurers for lower prices

MRNA

Today's session highlights significant options activity in healthcare stocks, indicating potential trading opportunities. Notable transactions include bearish put sweeps for PFE and CGC, and bullish call sweeps for ROIV, ABVX, EWTX, MRNA, UNH, CAH, and LLY. These activities suggest varying market sentiments and potential price movements in these stocks.

benzinga_article

Cardinal Health

Moderna

Unitedhealth

10 Health Care Stocks Whale Activity In Today's Session

Vice President Silvana Battaglia of Cencora Inc filed a Form 144 with the SEC to sell 1,677 restricted shares on December 19, 2025, through Fidelity Brokerage Services. This filing allows the sale within 90 days.

VP Battaglia Files To Sell 1,677 Of Cencora Inc [COR]

LDOS

Officer Elizabeth A. Porter of Leidos Holdings Inc filed a Form 144 with the SEC to sell 3,000 shares on December 19, 2025, through Citigroup Global Markets Inc, under a prearranged trading plan (10b5-1). This filing allows the sale of restricted stock within 90 days.

Leidos

Officer Porter Files To Sell 3,000 Of Leidos Holdings Inc [LDOS]

TROW

T. Rowe Price Group, Inc. has reduced its indirect voting rights in Kion Group AG to 4.99%, now holding 6,544,197 voting rights attached to shares. A negligible amount of voting rights are held through shares on loan. This change was disclosed by Kion Group AG via EQS News on December 19, 2025.

T. Rowe Price

T. Rowe Price Group Reduces Total Voting Rights in Kion Group AG to 4.99%

The U.S. macroeconomic environment is favorable, with moderated growth and resilient demand. The Federal Reserve has cut interest rates to support the labor market. For risk-averse investors, large-cap blend mutual funds like Fidelity Mega Cap Stock Fund, T. Rowe Price U.S. Equity Research Fund, and Northern Large Cap Core are recommended. These funds offer a balance of growth and value, with strong returns and low expense ratios. They invest in large-cap stocks, providing stability and diversification.

Talkmarkets

3 Large-Cap Blend Mutual Funds To Buy Ahead Of 2026

Omnicom Group Inc.'s stock fell 1.26% to $81.66 on Thursday, underperforming compared to competitors. This decline ended a seven-day winning streak, with the stock closing 9.07% below its 52-week high. The trading volume was higher than the 50-day average. The S&P 500 and Dow Jones both rose during the session.

Dow Jones

Omnicom Group Inc. Stock Underperforms Thursday When Compared To Competitors

T. Rowe Price has launched two new active ETFs, TACU and TACN, targeting U.S. and international stocks with a 13-month fee waiver. TACU focuses on large-cap U.S. stocks, while TACN targets international stocks. Both ETFs combine active management with cost-efficient structures. Post-waiver, TACU and TACN will charge 0.14% and 0.20% fees, respectively. These additions bring T. Rowe Price's total ETF offerings to 30.

T. Rowe Price Adds Two Active ETFs Targeting US and International Stocks, With A Fee Waiver

Oestreicher David Vice President of Price (T Rowe) Group Inc [TROW] filed a Form 4 on December 18, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/17/25TransactionGiftShares400Price$0.00ValueN/AEnding Holdings: 129,467 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

VP Oestreicher Gifts 400 Of Price (T Rowe) Group Inc [TROW]